Agomab Therapeutics Closes $200 Million IPO
I'm PortAI, I can summarize articles.
05:28 PM EST, 02/09/2026 (MT Newswires) -- Agomab Therapeutics ( AGMB ) said late Monday it closed its initial public offering of 12.5 million American depository shares at a public offering price of $16 per ADS, raising about $200 million in gross proceeds before underwriting fees and expenses.The American depository shares started trading on the Nasdaq Global Select Market on Feb. 6. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments